Ovarian Cancer Action (OCA) is the UK’s ovarian cancer research charity. We fund research to save lives and are proud to have invested over £11.5m in research to date. For more than 30 years we have hosted and curated the international HHMT forum on ovarian cancer, which will meet next in September 2019 in the UK.
UPDATE: Applications for the Immunotherapy Challenge have now closed. We have been blown away by the number and quality of applications we’ve received from all around the world - from the US, Canada, Australia and all across Europe and the UK. It is fantastic to see how much excitement there is for research to unlock the benefits of immunotherapy for ovarian cancer. We will now be reviewing these applications over the coming months and will announce the winner later in the Autumn.
At the forum, we are awarding a significant grant of up to £600,000 for an immunotherapy or immunology based research project to improve outcomes and transform treatment for women with ovarian cancer. The final shortlisted candidates will also be invited to present at the forum.
We want to hear from talented scientists from around the world who share our ambition to see women with ovarian cancer benefit from advances in immunotherapy. Applications for this grant are now open.
Applicants should have conducted independent research in the field of immunotherapy or immunology and ovarian cancer. We actively welcome applications from wider experts in the field of immunotherapy and immunology, however a co-applicant should be included whose specialty is ovarian cancer.
We are committed to supporting young investigators in ovarian cancer and or immunological research and welcome applications from talented postdoctoral researchers or that include a plan for mentoring early career scientists.
We are also happy to receive applications that are not for the full £600,000 and will consider awarding more than one grant for the right projects. Costs requested must not exceed this cap.
The successful project should enrich scientific understanding of the disease, with the overall ambition to improve survival rates for women with ovarian cancer.
For more information please download the Immunotherapy Challenge terms of reference, including information on eligibility, how to apply and timelines.
If you have any queries regarding this application please contact the Research Team on email@example.com or call +44 (0)20 7380 1730